SCHEMBL18680907

SCHEMBL18680907

CCSc1cc(F)ccc1OC

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.44
IDO1 P14902 1/20 0.40
NFE2L2 Q16236 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
USP2 O75604 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HTR2A P28223 3/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
HTR2C P28335 2/20 0.37
HTR2B P41595 2/20 0.37
SLC6A2 P23975 2/20 0.37
SLC6A4 P31645 2/20 0.37
SLC6A3 Q01959 2/20 0.37
ALDH1A1 P00352 1/20 0.37
PKM P14618 1/20 0.37
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13700993 0.79 ACHE (0.52) KDM4EMEN1KMT2AUSP2SMN1; SMN2
SCHEMBL16885084 0.79 LMNA (0.45) KDM4EIDO1MEN1KMT2ASMN1; SMN2
SCHEMBL4803339 0.78 ALDH1A1 (0.42) KDM4EMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL20563209 0.77 HTR2C (0.38) KDM4EIDO1NFE2L2MEN1KMT2A
SCHEMBL8444448 0.76 MTNR1A (0.51) KMT2AL3MBTL1ALDH1A1PKMTDP1
SCHEMBL21371993 0.76 AR (0.52) HTR2AHTR2CHTR2BSLC6A2SLC6A4
SCHEMBL31682767 0.75 NPC1 (0.49) KDM4EMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL5882272 0.74 ALDH1A1 (0.58) MEN1KMT2ASMN1; SMN2L3MBTL1ALDH1A1
SCHEMBL779536 0.72 DDR1 (0.38) IDO1HTR2AHTR2CHTR2BALDH1A1
SCHEMBL321697 0.72 KDM4E (0.53) KDM4ENFE2L2MEN1KMT2AUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2501236-B1 N-[2-fluoro-3-(4-amino-7H-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-phenyl]-4-benzenesulfonamide derivatives as Raf protein kinase modulators for the treatment of cancer PLEXXIKON INC (US) 2017-03-29 EP disclosed